ADVANCED OR METASTATIC SOLID TUMOR
Clinical trials for ADVANCED OR METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study seeks right dose for cancer drug in patients with liver issues
Disease control Recruiting nowThis early-phase study aims to find a safe starting dose of the drug sacituzumab govitecan for people with advanced solid tumors who also have moderate liver impairment. About 30 participants will receive the drug to monitor side effects and how the drug moves through the body. T…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New combo aims to revive immunotherapy in resistant cancers
Disease control Recruiting nowThis early-phase study tests a new drug (PLN-101095) alone and with pembrolizumab in adults whose advanced solid tumors have stopped responding to standard immunotherapy. The goal is to see if the combination is safe and can shrink tumors or slow their growth. About 124 participa…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Pliant Therapeutics, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC